Doctor profile · Federal record
Dr. JOSE PANDO, MD
Rheumatology Physician (CMS: RHEUMATOLOGY) · LEWES, DE
- NPI 1306839048
- Accepts Medicare
- MIPS 82.1 / 100 · 2023
- 40 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
20268 PLANTATIONS RD
LEWES, DE 199584622
(302) 644-2633
fax (302) 644-9192 - Additional location
-
35141 Atlantic Ave
Millville, DE 199676954 - Additional location
-
509 Lakeview Ave
Milford, DE 199632917
(302) 644-9192
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- November 4, 2025
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Delaware #C1-0004876
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306839048. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
318,695
Distinct HCPCS
10
Medicare allowed
$4,089,078
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 134,000 | 41 | $5 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 55,230 | 55 | $9 | |
J3262 |
Injection, tocilizumab, 1 mg | 54,081 | 15 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 24,060 | 256 | $23 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 18,450 | 30 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 10,680 | 44 | $33 | |
J1306 |
Injection, inclisiran, 1 mg | 10,224 | 20 | $11 | |
J9312 |
Injection, rituximab, 10 mg | 5,250 | 22 | $74 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,001 | 571 | $126 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 894 | 589 | $89 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 9,538. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$8,021
Transactions
120
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 12 | $4,909.15 | |
| Amgen Inc. | 18 | $632.89 | |
| ABBVIE INC. | 17 | $403.95 | |
| Janssen Biotech, Inc. | 11 | $370.56 | |
| Novartis Pharmaceuticals Corporation | 9 | $223.00 | |
| Mallinckrodt Hospital Products Inc. | 6 | $205.41 | |
| PFIZER INC. | 9 | $187.53 | |
| Lilly USA, LLC | 8 | $180.06 | |
| UCB, Inc. | 8 | $142.67 | |
| Aurinia Pharma U.S., Inc. | 1 | $133.89 | |
| Radius Health, Inc. | 4 | $120.65 | |
| AstraZeneca Pharmaceuticals LP | 8 | $117.25 | |
| Fresenius Kabi USA, LLC | 3 | $62.23 | |
| Alexion Pharmaceuticals, Inc. | 3 | $57.58 | |
| Organon Llc | 3 | $51.86 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,268
Patients
1,077
Total drug cost
$1,201,389
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 859 | 318 | $10,837 |
| Hydroxychloroquine Sulfate | Generic | 506 | 168 | $42,218 |
| Methotrexate (Methotrexate Sodium) | Brand | 482 | 155 | $18,750 |
| Leflunomide | Generic | 195 | 69 | $23,163 |
| Allopurinol | Generic | 163 | 49 | $2,767 |
| Alendronate Sodium | Generic | 152 | 49 | $2,225 |
| Gabapentin | Generic | 144 | 52 | $2,969 |
| Tramadol Hcl | Generic | 132 | 42 | $1,652 |
| Sulfasalazine | Generic | 128 | 42 | $3,915 |
| Tizanidine Hcl | Generic | 127 | 44 | $1,588 |